Pfizer Vaccine for Children 5 to 11 is Safe with Robust Antibody Response
By Stacy M. Brown NNPA Newswire Senior National Correspondent @StacyBrownMedia A Phase 2/3 trial conducted by Pfizer and BioNTech revealed that the Covid-19 vaccine was safe and ge…
